Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

sevelamer

sevelamer
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Renvela POWDER, ORAL carbonate 0.8 g      
Renagel TABLET, ORAL hydrochloride 400 mg, hydrochloride 800 mg    
Renvela TABLET, ORAL carbonate 800 mg      
VIEW MORE Phosphate-removing Agents
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

sevelamer (Renagel)

  • All Formulations

sevelamer (Renvela)

  • 800 mg carbonate tablet oral

Dose equivalency is 1:1. Round Renagel dose to nearest 800 mg increment of Renvela.

Reviewed: April 22, 2008 (Renvela), and 24 May 2016 (update)

Last updated: Dec. 18, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved